|
|
|
Zabolante Tab.
Dongwha Cefaclor Cap. / Syr.
Dongwha Ofloxacin Tab.
Roximycin Tab.
Cipoxacin Tab. 250mg
Zabolante Tab.
Pamoxin Tab.
Pamockle Tab.
Falexin Cap.
Category
Ethical > Antibiotics
Indications
1. Effective strain
1) Gram-positive bacteria: Streptococcus pneumoniae (including penicillin-resistant bacteria, macrolide-resistant bacteria and multidrug-resistant bacteria*), Streptococcus pyogenes, Staphylococcus aureus (including methicillin-sensitive and resistant bacteria), methicillin-sensitive and resistant coagulase-negative staphylococcus (MSCNS/MRCNS), Enterococcus faecalis, and Enterococcus faecium (including Vancomycin-resistant enterococcus faecium)
2) Gram-negative bacteria: Acinetobacter such as Hemophilus influenzae, Moraxella catarrhais, Klebsiella pneumoniae, Klebsiella oxytoca, E. coli, Neisseria gonorrhoae, Acinetobacter baumannii, Acinetobacter calcoaceticus, Enterobacter cloaceticus, Enterobacter prucei, Citrobacter prundii, Citrobacter prundii, Serratia marcescens, Serratia marcescens, Morganella morganii, Proteus mirabilis, Proteus mirabilis, Proteus bulgaris, Proteus bulgaris, and Stenotrophomonas maltophilia, Stenotrophomonas maltophilia, Salmonella typilia, Salmonella typhoid, Salmonella typhi, and Salmonella typi typhi), 녹농균(Pseudomonas aeruginosa)
3) Disjunctive bacteria: Mycoplasma such as Mycoplasma pneumoniae, Mycoplasma hominis, Chlamydophila pneumoniae, Legionella pneumoniae, etc
*Multidrug-resistant bacteria: Anti-drug resistant pneumococci refers to strains that are resistant to two or more antimicrobials at the same time, among penicillin, second-generation cephalosporin (such as cefuroxime), and macrolide.
2. Indication
Respiratory infection: acute exacerbation of chronic obstructive pulmonary disease (including chronic bronchitis and emphysema)
Since fluoroquinolone drugs, including this drug, are associated with significant adverse reactions, acute bacterial deterioration of chronic obstructive pulmonary disease, including chronic bronchitis, is used in patients with no other treatment options.
Dosage
Adult jabofloxacin is administered once a day, one tablet (366.69 mg) is administered orally regardless of diet, and the recommended duration of administration is 5 days.
Patients with mild renal impairment do not need dose control.
Packing Unit
20T(5T/Alu-Alu Packaging x4)
5T(5T/Alu-Alu Packaging)
Ingredients
Zabofloxacin D-Aspartate Hydrate ........... 512.98mg(366.69mg as Zabofloxacin)